跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Is Changing Cancer Drug Discovery

1Why Cancer Drug Discovery Is So Hard2What AI Can and Cannot Do Here3Finding the Right Target4Designing Molecules with AI5Testing, Trials, and Real-World Impact6What's Next and What to Watch
Finding the Right Target

What a Drug Target Actually Is

1 / 3
Look at the cancer cell first, then at the single protein the diagram marks as the target. Everything else in the cell is context; the drug is built for that one molecule, the way a key is cut for one lock. Now compare it with the healthy cell beside it. The same protein is there, doing its normal job. That is the tension at the heart of target choice: if the tumor depends on this protein more than healthy tissue does, blocking it hurts the tumor more than the patient. And notice the shape of the protein — a drug has to physically fit somewhere on it. A target that matters biologically but offers no place for a drug to bind is still a dead end. So a target has to pass three tests at once: important to the tumor, different enough from healthy tissue, and reachable by a medicine.
0:00 / 0:00

A drug target is a specific molecule in the body — almost always a protein — whose behavior a medicine is designed to change. In cancer, the target is usually a protein that helps the tumor cell grow, survive, divide, or evade the immune system. The medicine does not act on the cancer as a whole; it acts on one molecule, and the rest of the effect follows from what that molecule does.

A useful way to picture it: a cancer cell is a crowded city, and a target is one specific door that the drug is built to fit. The drug is a key shaped for that door. If the door is on a building the tumor depends on, turning the key can slow the tumor. If the door is also used by healthy tissue, turning it causes side effects.

This is why the choice of target is made before any drug molecule exists. The target defines what the drug must do, what it must avoid doing, and what evidence would count as success. Two properties matter most. First, the target should be genuinely important to the tumor — often the tumor carries an altered or overactive version of the protein, so the tumor depends on it more than healthy cells do. Second, the target should be reachable and changeable by a drug: a protein buried deep inside a cell, or one whose shape offers no place for a drug to bind, is a poor target even if it matters biologically.

A target is therefore not simply 'something cancer needs'. It is a molecule that is important to the tumor, distinct enough from healthy tissue to be tolerable, and physically accessible to a medicine. Those three conditions rarely hold at once, which is why so few candidates survive the selection step.

上一页1 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion